Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

• Status: Withdrawn
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether a perioperative course of gabapentin in parturients on buprenorphine maintenance would improve analgesia after elective cesarean delivery (CD).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vanderbilt University Medical Center
• Treatments: Buprenorphine; Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

• singleton, term pregnancy

• currently on buprenorphine maintenance therapy

• scheduled for elective CD under spinal anesthesia

Exclusion Criteria:

• use illicit drugs or relapse during the last trimester of pregnancy

• positive drug screen at the time of delivery

• allergies to any medications used in the study

• taking prescribed gabapentin at the time of admission for CD

• contraindications to neuraxial anesthesia or require general anesthesia for CD

• designated ASA physical status 4 or above